PDF《新世纪医疗控股有限公司》

C

1 C Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

New Century Healthcare Holding Co. Limited 新世纪医疗控股有限公司(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1518) CHANGE IN NON-EXECUTIVE DIRECTOR AND COMPOSITION OF AUDIT COMMITTEE The board of directors (the Board ) of New Century Healthcare Holding Co. Limited (the Company ) is pleased to announce that as reviewed and approved by the Board, Mr. GUO Qizhi (郭其志) ( Mr. Guo ) has been appointed as a non-executive director ( NED ) of the Company and a member of the Audit Committee of the Board (the Audit Committee ), with effect from January 1, 2018. Mr. Guo is appointed to succeed Dr. HE Xin (何欣) ( Dr. He ), a current NED of the Company who intends to retire from the Board on January 1,

2018 by reason of her desire to focus on her other work commitments. Dr. He has confirmed that she has no disagreement with the Board in any respect and there is no matter relating to her resignation that needs to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited (the Stock Exchange ). Following Dr. He'

s resignation from her position as an NED, she will also no longer serve as a member of the Audit Committee. Mr. Guo, aged 45, is currently a senior partner (高级合夥人) of CDH Venture and Growth Capital (鼎晖创新与成长基金), an investment fund established in

2015 focusing on healthcare, TMT (technology, media and telecommunications) and other innovation-based growth opportunities in the People'

s Republic of China (the PRC ). Mr. Guo joined CDH Equity Investment Management (Tianjin) Co., Ltd. (鼎晖股权投 资管理 (天津) 有限公司) ( CDH Investments ) in

2011 and serves as its executive director and manager director of operations (执行董事兼运营董事总经理), mainly responsible for investments in the medical sector. Mr. Guo also serves as a director of various medical companies in the PRC, including Nanjing Mingji Hospital Co., Ltd. (南 京明基医院有限公司), Suzhou Mingji Hospital Co., Ltd. (苏州明基医院有限公司), Mingji (Nanjing) Hospital Management Consulting Co., Ltd. (明基 (南京) 医院管理谘 询有限公司) and Zhejiang Dazhong Hospital (Group) Management Co., Ltd. (浙江大 中医院 (集团) 管理有限公司). C

2 C Mr. Guo received a bachelor'

s degree in engineering (工学学士学位) from Northeastern University (东北大学) in Shenyang city, Liaoning province, the PRC in

1994 and a master'

s degree in accounting (会计学硕士学位) from Liaoning University (辽宁大学) in the same city in 1998. Before joining CDH Investments in 2011, Mr. Guo had served as a vice president of operations and the chief financial officer (运 营副总裁兼财务总监) of China Resources Sanjiu Medical &

Pharmaceutical Co., Ltd. (华润三九医药股份有限公司) (listed on the Shenzhen Stock Exchange with stock code 000999), the general manager of strategic investments (策略投资总经 理) of the strategic investment department (战略投资部) of China Resources (Group) Co., Ltd. (华润 (集团) 有限公司), the chief financial officer (财务总监) of China Resources (Jilin) Bio-Chemical Co., Ltd. (吉林华润生化股份有限公司) (listed on the Shanghai Stock Exchange with stock code

600893 and now known as AECC Aviation Power Co., Ltd. (中国航发动力股份有限公司)), the financial manager (财务负责 人) of Shanghai Dare (Group) Co., Ltd. (上海大亚 (集团) 有限公司), and an industry researcher (行业研究员) of the research division (研究部) of Pingan Securities Co., Ltd. (平安证券股份有限公司). On November 23, 2017, Mr. Guo entered into a service contract with the Company which will commence from January 1,

2018 for an initial term of no more than three years and shall be terminable by either party giving not less than three months'

notice in writing to the other. Mr. Guo will be duly subject to retirement by rotation and re-election at the annual general meetings of the Company in accordance with the articles of association of the Company. Mr. Guo will not receive any remuneration for his position as an NED of the Company, be it under the aforesaid service contract or otherwise. As at the date of this announcement, Mr. Guo has declared that: (i) save for the appointment as an NED of the Company, he has not held any other directorships in any listed public companies in the last three years or any other positions with the Company and its subsidiaries;

(ii) he does not have any relationships with any director, senior management, substantial shareholder or controlling shareholder of the Company;

and (iii) he does not have any interests in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter

571 of the Laws of Hong Kong). Save as disclosed above, Mr. Guo has confirmed that there is no other information required to be disclosed pursuant to any of the requirements of Rule 13.51(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the Company is not aware of any other matters relating to the appointment of Mr. Guo that need to be brought to the attention of the shareholders of the Company or the Stock Exchange. C

3 C The Board firmly believes that Mr. Guo will make a significant contribution to the Company with his extensive experience and valuable expertise in the financial services and healthcare industries, and takes this opportunity to acknowledge Dr. He'

s contributions to the Company with the highest regard and deepest gratitude. By order of the Board New Century Healthcare Holding Co. Limited Mr. Jason ZHOU Chairman, Executive Director and Chief Executive Officer Beijing, the PRC, November 23,

2017 As of the date of this announcement, the executive directors of the Company are Mr. Jason ZHOU, Ms. XIN ........